Eisai’s Nichi-Iko Deal Marks Watershed in Generic Biz of Research-Driven Makers

By Reiji Anasako Eisai is offloading its generic subsidiary Elmed Eisai to Japan’s largest generic maker, Nichi-Iko Pharmaceutical. Among innovative pharma companies, it is the first divestment of a generic business since one by Mitsubishi Tanabe Pharma a year ago,...read more